WallStSmart

USBC, Inc. (USBC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

USBC, Inc. stock (USBC) is currently trading at $0.34. USBC, Inc. PS ratio (Price-to-Sales) is 6266.19. WallStSmart rates USBC as Sell.

  • USBC PE ratio analysis and historical PE chart
  • USBC PS ratio (Price-to-Sales) history and trend
  • USBC intrinsic value — DCF, Graham Number, EPV models
  • USBC stock price prediction 2025 2026 2027 2028 2029 2030
  • USBC fair value vs current price
  • USBC insider transactions and insider buying
  • Is USBC undervalued or overvalued?
  • USBC, Inc. financial analysis — revenue, earnings, cash flow
  • USBC Piotroski F-Score and Altman Z-Score
  • USBC analyst price target and Smart Rating
USBC

USBC, Inc.

NYSE MKTTECHNOLOGY
$0.34
$0.01 (-3.12%)
52W$0.33
$5.36

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

USBC, Inc. (USBC) · 5 metrics scored

Smart Score

16
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.

USBC, Inc. (USBC) Key Strengths (1)

Avg Score: 8.0/10
Price/BookValuation
1.588/10

Trading at 1.58x book value, attractively priced

USBC, Inc. (USBC) Areas to Watch (4)

Avg Score: 1.8/10
Return on EquityProfitability
-46.60%0/10

Company is destroying shareholder value

Price/SalesValuation
6266.192/10

Very expensive at 6266.2x annual revenue

Institutional Own.Quality
0.95%2/10

Very low institutional interest at 0.95%

Market CapQuality
$137M3/10

Micro-cap company with very limited liquidity and high volatility

Supporting Valuation Data

Price/Sales (TTM)
6266.19
Overvalued
EV/Revenue
4115.24
Overvalued

USBC, Inc. (USBC) Detailed Analysis Report

Overall Assessment

This company scores 16/100 in our Smart Analysis, earning a F grade. Out of 5 metrics analyzed, 1 register as strengths (avg 8.0/10) while 4 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Book. Valuation metrics including Price/Book (1.58) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Price/Sales, Institutional Own.. Some valuation metrics including Price/Sales (6266.19) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -46.60%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -46.60% needing improvement to support the investment thesis. Third, top-line growth trajectory.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Price/Sales are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

USBC Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

USBC's Price-to-Sales ratio of 6266.19x sits near its historical average of 6266.19x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 6266.19x set in Mar 2026, and 0% above its historical low of 6266.19x in Mar 2026.

Compare USBC with Competitors

Top SCIENTIFIC & TECHNICAL INSTRUMENTS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for USBC, Inc. (USBC) · TECHNOLOGYSCIENTIFIC & TECHNICAL INSTRUMENTS

The Big Picture

USBC, Inc. operates as a stable business with moderate growth and solid fundamentals.

Key Findings

Negative Free Cash Flow

Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Volatility is elevated with a beta of 1.67, so expect amplified moves relative to the broader market.

Sector dynamics: monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive moves, and regulatory changes that could impact USBC, Inc..

Bottom Line

USBC, Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Total Buys
0
Total Sells
0

Data sourced from SEC Form 4 filings

Last updated: 2:28:46 PM

About USBC, Inc.(USBC)

Exchange

NYSE MKT

Sector

TECHNOLOGY

Industry

SCIENTIFIC & TECHNICAL INSTRUM...

Country

USA

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. The company is headquartered in Gleason, Tennessee.